FI973357A - Verisuonen tromboosin ja uudelleen ahtautumisen hoito sisään hengitetyllä typpioksidilla - Google Patents

Verisuonen tromboosin ja uudelleen ahtautumisen hoito sisään hengitetyllä typpioksidilla Download PDF

Info

Publication number
FI973357A
FI973357A FI973357A FI973357A FI973357A FI 973357 A FI973357 A FI 973357A FI 973357 A FI973357 A FI 973357A FI 973357 A FI973357 A FI 973357A FI 973357 A FI973357 A FI 973357A
Authority
FI
Finland
Prior art keywords
restenosis
treatment
nitric oxide
inhaled nitric
vascular thrombosis
Prior art date
Application number
FI973357A
Other languages
English (en)
Swedish (sv)
Other versions
FI119912B (fi
FI973357A0 (fi
Inventor
Warren M Zapol
Kenneth D Bloch
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23537703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI973357(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of FI973357A publication Critical patent/FI973357A/fi
Publication of FI973357A0 publication Critical patent/FI973357A0/fi
Application granted granted Critical
Publication of FI119912B publication Critical patent/FI119912B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI973357A 1995-02-16 1997-08-15 Kaasumaisen typpioksidin käyttö lääkkeen valmistamiseksi verisuonen uudelleen ahtautumisen hoitamiseksi FI119912B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38930495 1995-02-16
US08/389,304 US6063407A (en) 1995-02-16 1995-02-16 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US9601745 1996-02-08
PCT/US1996/001745 WO1996025184A1 (en) 1995-02-16 1996-02-08 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide

Publications (3)

Publication Number Publication Date
FI973357A true FI973357A (fi) 1997-08-15
FI973357A0 FI973357A0 (fi) 1997-08-15
FI119912B FI119912B (fi) 2009-05-15

Family

ID=23537703

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973357A FI119912B (fi) 1995-02-16 1997-08-15 Kaasumaisen typpioksidin käyttö lääkkeen valmistamiseksi verisuonen uudelleen ahtautumisen hoitamiseksi

Country Status (19)

Country Link
US (2) US6063407A (fi)
EP (1) EP0810884B1 (fi)
JP (1) JP3956055B2 (fi)
KR (1) KR100426528B1 (fi)
CN (1) CN1327826C (fi)
AR (1) AR000960A1 (fi)
AT (1) ATE324866T1 (fi)
AU (1) AU690425B2 (fi)
BR (1) BR9607616A (fi)
CZ (1) CZ289677B6 (fi)
DE (1) DE69636096T2 (fi)
DK (1) DK0810884T3 (fi)
ES (1) ES2263159T3 (fi)
FI (1) FI119912B (fi)
HU (1) HUP9802093A3 (fi)
NO (1) NO315355B1 (fi)
PT (1) PT810884E (fi)
WO (1) WO1996025184A1 (fi)
ZA (1) ZA961183B (fi)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
USRE37234E1 (en) 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
EP0941086A4 (en) * 1996-11-01 2000-07-12 Nitromed Inc NITROSIZED AND NITROSYLATED PHOSPHODIESTERASE INHIBITING COMPOUNDS, COMPOSITIONS AND THEIR USE
CA2302023A1 (en) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries Ltd. Angiogenesis promoter
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
WO2000027293A1 (en) * 1998-11-06 2000-05-18 University Of Rochester A method to improve circulation to ischemic tissue
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US6612306B1 (en) 1999-10-13 2003-09-02 Healthetech, Inc. Respiratory nitric oxide meter
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
AU7007001A (en) 2000-06-22 2002-01-02 Nitromed Inc Nitrosated and nitrosylated taxanes, compositions and methods of use
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
BRPI0113085B1 (pt) * 2000-08-11 2017-09-19 R. Whitlock David Preparation to be applied to a surface of an individual understanding ammonia oxidizing bacteria that metabolize transparation, and clothing article
WO2002024208A1 (en) * 2000-09-20 2002-03-28 Aquamed Technologies, Inc. Compositions comprising lignin and methods of making and using the same
AU2001296456A1 (en) 2000-09-29 2002-04-08 Healthetech, Inc. Indirect calorimetry system
IL155524A0 (en) * 2000-10-26 2003-11-23 Fournier Lab Ireland Ltd Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
WO2003000114A2 (en) 2001-06-21 2003-01-03 Beth Israel Deaconess Medical Center Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
US20070173460A1 (en) * 2001-09-20 2007-07-26 Oculus Innovative Sciences, Inc. Compositions comprising lignin and methods of making and using the same
US20030070674A1 (en) * 2001-10-12 2003-04-17 Bryan Perry Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US20040110691A1 (en) * 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
US6627602B2 (en) * 2001-11-13 2003-09-30 Duke University Preventing desensitization of receptors
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
AU2003222569A1 (en) * 2002-01-11 2003-07-24 Whitlock, David R. Compositions including ammonia oxidizing bacteria and methods of using same
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
US20040131703A1 (en) * 2002-06-21 2004-07-08 Bach Fritz H. Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
WO2005007173A1 (en) * 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Use of nitrite salts for the treatment of cardiovascular conditions
WO2005030147A2 (en) * 2003-09-26 2005-04-07 Whitlock David R Methods of using ammonia oxidizing bacteria
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
MXPA06013111A (es) * 2004-05-11 2007-05-23 Sensormedics Corp Dosificacion intermitente de gas de oxido nitrico.
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
US20070116785A1 (en) * 2005-11-18 2007-05-24 Miller Christopher C Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
WO2008063868A2 (en) * 2006-11-07 2008-05-29 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US8434475B2 (en) * 2008-01-31 2013-05-07 Genosys, Inc. Nitric oxide reactor and distributor apparatus and method
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8501090B2 (en) * 2008-03-24 2013-08-06 Christian S. Minton Anti-microbial gas apparatus and method
US11000484B2 (en) * 2008-07-24 2021-05-11 Vero Biotech LLC Methods for diagnosing and treating a heart condition in a patient
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US8685467B2 (en) 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
US20120107423A1 (en) 2010-11-01 2012-05-03 Ino Therapeutics Llc Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome
WO2013070592A1 (en) 2011-11-07 2013-05-16 The General Hospital Corporation Treatment of red blood cells
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
WO2015048747A1 (en) * 2013-09-30 2015-04-02 Northwestern University Targeted therapy for the prevention of restenosis in the cardiovascular system
US9381212B2 (en) 2014-01-10 2016-07-05 Mallinckrodt Hospital Products IP Limited Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
EP4219679A3 (en) 2014-04-15 2023-08-09 Aobiome LLC Ammonia-oxidizing nitrosomonas eutropha strain d23
GB2542064B (en) * 2015-01-20 2020-11-18 Univ California Unit aerosol doses for anticoagulation
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
WO2023081681A1 (en) * 2021-11-03 2023-05-11 Baxter International Inc. Nitric oxide donors for use in surgical recovery

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3785377A (en) * 1970-11-12 1974-01-15 S Jorgensen Plant, preferably for anaesthesia
US4010897A (en) * 1976-03-31 1977-03-08 Charles F. Kettering Foundation Method and apparatus for home production and application of nitrogen fertilizer
IL57239A (en) * 1979-05-08 1982-04-30 Alamaro Moshe Production of nitric oxides
US4297123A (en) * 1980-02-07 1981-10-27 Wyse Harold G Method and apparatus for producing a nitrate fertilizer
US4336798A (en) * 1980-10-06 1982-06-29 Anthony V. Beran Medical corrugated respiratory tube
SE438261B (sv) * 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4534343A (en) * 1984-01-27 1985-08-13 Trutek Research, Inc. Metered dose inhaler
US4592348A (en) * 1984-12-17 1986-06-03 Waters Iv William C Aerosol inhaler
CN87107609A (zh) * 1987-11-12 1988-09-14 赵树杰 脑血栓治疗仪
US4852561A (en) * 1988-07-27 1989-08-01 Sperry C R Inhalation device
US4877589A (en) * 1988-09-19 1989-10-31 Hare Louis R O Nitrogen fixation by electric arc and catalyst
US4915915A (en) * 1988-10-11 1990-04-10 Treharne Richard W Water-powdered piezoelectric unit for producing nitrogen fertilizer
US4954526A (en) * 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5396882A (en) * 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DE122008000012I2 (de) * 1990-12-05 2012-04-12 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefassverengung und von Asthma.
IL101406A (en) * 1991-03-29 1998-02-08 Brigham & Womens Hospital Pharmaceutical compositions containing s-nitrosothiol derivatives
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
US5185376A (en) * 1991-09-24 1993-02-09 The United States Of America As Represented By The Department Of Health And Human Services Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
AU3237193A (en) * 1991-12-11 1993-07-19 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
CN1083707A (zh) * 1992-09-05 1994-03-16 沈阳康达制药厂 一种脑血栓片的生产工艺
FR2695831B1 (fr) * 1992-09-24 1994-11-10 Air Liquide Installation et procédé de fourniture d'un mélange gazeux aux voies respiratoires d'un utilisateur.
WO1994016729A1 (en) * 1993-01-28 1994-08-04 Neorx Corporation Targeted nitric oxide pathway or nitric oxide synthase modulation
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5861168A (en) * 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5428070A (en) * 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
DE69423905T2 (de) * 1993-07-06 2000-10-05 Aerocrine Ab, Danderyd System zur feststellung von no-pegeln in ausgeatmeter luft und diagnostische verfahren für zu abnormalen no-pegeln in beziehung stehenden abweichungen
DE4327731C1 (de) * 1993-08-18 1994-11-10 Messer Griesheim Gmbh NO-haltiges Gasgemisch zur Behandlung pulmonaler Erkrankungen
DE4327732C1 (de) * 1993-08-18 1994-09-01 Messer Griesheim Gmbh NO-haltiges Gasgemisch zur Behandlung pulmonaler Erkrankungen
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5660873A (en) * 1994-09-09 1997-08-26 Bioseal, Limited Liability Corporaton Coating intraluminal stents
US5521191A (en) * 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
EP1609477B1 (en) * 1994-12-12 2011-11-09 Omeros Corporation Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
US5823180A (en) * 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
CN1208053C (zh) * 1996-04-05 2005-06-29 综合医院公司 气体氧化氮在制备用于治疗血红蛋白病的冶疗气体中的应用

Also Published As

Publication number Publication date
EP0810884A4 (en) 2002-05-08
ZA961183B (en) 1996-12-17
HUP9802093A3 (en) 2001-02-28
CN1174513A (zh) 1998-02-25
AR000960A1 (es) 1997-08-27
FI119912B (fi) 2009-05-15
NO315355B1 (no) 2003-08-25
AU690425B2 (en) 1998-04-23
KR19980702187A (ko) 1998-07-15
EP0810884B1 (en) 2006-05-03
JP3956055B2 (ja) 2007-08-08
ES2263159T3 (es) 2006-12-01
PT810884E (pt) 2006-08-31
AU4777596A (en) 1996-09-04
DK0810884T3 (da) 2006-08-28
CZ259897A3 (cs) 1998-05-13
MX9706257A (es) 1997-11-29
ATE324866T1 (de) 2006-06-15
NO973768L (no) 1997-10-15
BR9607616A (pt) 1998-06-09
DE69636096T2 (de) 2006-12-07
WO1996025184A1 (en) 1996-08-22
DE69636096D1 (de) 2006-06-08
JPH11500125A (ja) 1999-01-06
US5904938A (en) 1999-05-18
US6063407A (en) 2000-05-16
KR100426528B1 (ko) 2004-06-30
HUP9802093A2 (hu) 2000-06-28
EP0810884A1 (en) 1997-12-10
CZ289677B6 (cs) 2002-03-13
FI973357A0 (fi) 1997-08-15
CN1327826C (zh) 2007-07-25
NO973768D0 (no) 1997-08-15

Similar Documents

Publication Publication Date Title
FI973357A (fi) Verisuonen tromboosin ja uudelleen ahtautumisen hoito sisään hengitetyllä typpioksidilla
DE69415068D1 (de) Mikromotor und Herstellungsverfahren desselben
DE69403461D1 (de) Katheter und herstellungsverfahren
DE69217134D1 (de) Katheterführungsdraht und Katheter
DE69117656D1 (de) Therapiehandschuh und Herstellungsverfahren
FI971969A (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
BR9201317A (pt) Acolchoamento absorvente e metodo de se manufatura o mesmo
EP0719791A3 (en) Drugs for the treatment of restenosis and arterial sclerosis
FR2701214B1 (fr) Cathéter et procédé de fabrication de celui-ci.
FI920424A (fi) Foerfarande foer anvaendning av metalliseringsanlaeggning och anordning foer utfoerande av foerfarandet
NO931779D0 (no) Fremgangsmaate for behandling av kondensater av ammoniakk og urea
FI965204A (fi) Bromelaiinin lääkekäyttö
DE69520268D1 (de) Behandlung von Legierungen und danach hergestellte Gegenstände
PL306093A1 (en) Cataract treating agent and method of obtaining same
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
NO961113D0 (no) Behandling og forebyggelse av prostatakreft
FI960342A (fi) Bentsoksatsinonit ja bentsotiatsinonit, joilla on terapeuttista aktiivisuutta
FI951494A0 (fi) Jyvien käsittely laajentimella
NO942686D0 (no) Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser
SE9201607D0 (sv) Intravasal tromolytisk behandling av embolier och tromboser
FR2748907B3 (fr) Utilisation des galles et derives galliques dans la fabrication des cigarettes et le traitement des tabacs
LV5401A3 (lv) Alergiskas bronhialas astmas profilakses un arstesanas panemiens
DE69410123D1 (de) Katheter und herstellungsverfahren
NO930644D0 (no) Absorpsjonsmiddel og anvendelse av dette
BR9600881A (pt) Conjunto introdutor de cateter e método de formar o mesmo

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119912

Country of ref document: FI

MM Patent lapsed